Tommaso Toffanin, MD, PhD, is a psychiatrist and clinical researcher at the University Hospital of Padua, Italy. He previously held a research position at the University of Ferrara.
His research focuses on the neurobiological mechanisms underlying severe psychiatric disorders, particularly schizophrenia, bipolar disorder, and major depressive disorder. His scientific work encompasses psychiatric genetics, neuroimaging, cognitive functioning, and translational investigations using olfactory neuroepithelium-derived cellular models to explore molecular and cellular alterations associated with psychiatric disorders.
His clinical and research interests also include psychiatric neuromodulation, particularly electroconvulsive therapy (ECT), transcranial magnetic stimulation (TMS), and vagus nerve stimulation (VNS), with special attention to treatment-resistant depression.
His work aims to integrate clinical psychiatry, molecular neuroscience, and innovative therapeutic approaches to advance biomarker discovery and precision psychiatry.
Tommaso Toffanin, MD, PhD, is a psychiatrist and clinical researcher at the University Hospital of Padua, Italy. He previously held a research position at the University of Ferrara.
His research focuses on the neurobiological mechanisms underlying severe psychiatric disorders, particularly schizophrenia, bipolar disorder, and major depressive disorder. His scientific work encompasses psychiatric genetics, neuroimaging, cognitive functioning, and translational investigations using olfactory neuroepithelium-derived cellular models to explore molecular and cellular alterations associated with psychiatric disorders.
His clinical and research interests also include psychiatric neuromodulation, particularly electroconvulsive therapy (ECT), transcranial magnetic stimulation (TMS), and vagus nerve stimulation (VNS), with special attention to treatment-resistant depression.
His work aims to integrate clinical psychiatry, molecular neuroscience, and innovative therapeutic approaches to advance biomarker discovery and precision psychiatry.